Uiwang-si, South Korea

Min-Hee Son

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Min-Hee Son: Innovator in Pharmaceutical Composition

Introduction

Min-Hee Son is a notable inventor based in Uiwang-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral compositions that incorporate taxanes. With a total of four patents to his name, Son's work is paving the way for advancements in drug delivery systems.

Latest Patents

Among his latest patents, one includes a pharmaceutical composition for oral administration comprising taxane. This composition features a combination of a taxane, a medium chain triglyceride, an oleoyl glycerol complex, a surfactant, and optionally, polyoxyl glyceryl fatty acid ester. Another notable patent is a pharmaceutical composition for oral administration comprising high concentration taxane. This invention includes a specific percentage of taxane, medium chain triglyceride, monooleoyl glycerol, surfactant, and polyoxyl glyceryl fatty acid ester, showcasing his innovative approach to enhancing drug efficacy.

Career Highlights

Min-Hee Son is currently associated with Dae Hwa Pharma Co., Ltd., where he continues to develop groundbreaking pharmaceutical solutions. His expertise in formulating effective drug compositions has positioned him as a key player in the pharmaceutical industry.

Collaborations

Son collaborates with talented individuals such as In-Hyun Lee and Yeong-Taek Park, contributing to a dynamic team focused on advancing pharmaceutical research and development.

Conclusion

Min-Hee Son's innovative work in pharmaceutical compositions demonstrates his commitment to improving drug delivery methods. His contributions are vital to the ongoing evolution of the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…